Identification of Acyl-Protein Thioesterase-1 as a Polysorbate-Degrading Host Cell Protein in a Monoclonal Antibody Formulation Using Activity-Based Protein Profiling

被引:2
|
作者
Sprager, Ernest [1 ,2 ]
Moeller, Jens [3 ]
Lin, Yuhsien [3 ]
Reisinger, Veronika [3 ]
Bratkovic, Tomaz [1 ]
Lunder, Mojca [1 ]
Vasl, Jozica [2 ]
Krajnc, Aleksander [2 ]
机构
[1] Univ Ljubljana, Fac Pharm, Ljubljana, Slovenia
[2] Novartis Pharmaceut Mfg LLC, Novartis Tech Res & Dev, Biol Tech Dev Menge, Ljubljana, Slovenia
[3] Novartis Pharmaceut Mfg GmbH, Novartis Tech Res & Dev, Analyt Characterizat, Kundl, Austria
关键词
Antibody drug(s); Enzyme(s); Protein formulation(s); Hydrolysis; Liquid Chromatography-Mass spectrometry (LC-MS); Monoclonal antibody(s); Surfactant(s); B-LIKE; 2; SERINE HYDROLASES; DEGRADATION; PROTEOMICS; PRODUCTS; IMPACT; HCPS; INHIBITION; HYDROLYSIS; STABILITY;
D O I
10.1016/j.xphs.2024.05.013
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Polysorbate (PS) degradation in monoclonal antibody (mAb) formulations poses a significant challenge in the biopharmaceutical industry. PS maintains protein stability during drug product's shelf life but is vulnerable to breakdown by low-abundance residual host cell proteins (HCPs), particularly hydrolytic enzymes such as lipases and esterases. In this study, we used activity-based protein profiling (ABPP) coupled with mass spectrometry to identify acyl-protein thioesterase-1 (APT-1) as a polysorbate-degrading HCP in one case of mAb formulation with stability problems. We validated the role of APT1 by matching the polysorbate degradation fingerprint in the mAb formulation with that of a recombinant APT1 protein. Furthermore, we found an agreement between APT1 levels and PS degradation rates in the mAb formulation, and we successfully halted PS degradation using APT1-specific inhibitors ML348 and ML211. APT1 was found to co-purify with a specific mAb via hitchhiking mechanism. Our work provides a streamlined approach to identifying critical HCPs in PS degradation, supporting quality-by-design principles in pharmaceutical development. (c) 2024 The Authors. Published by Elsevier Inc. on behalf of American Pharmacists Association. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)
引用
收藏
页码:2128 / 2139
页数:12
相关论文
共 50 条
  • [21] Combinatorial Optimization of Activity-Based Probes for Acyl Protein Thioesterases 1 and 2
    Vanhoutte, Roeland
    Verhelst, Steven H. L.
    ACS MEDICINAL CHEMISTRY LETTERS, 2022, : 1144 - 1150
  • [22] Identification and Characterization of Acyl-Protein Thioesterase 1/Lysophospholipase I As a Ghrelin Deacylation/Lysophospholipid Hydrolyzing Enzyme in Fetal Bovine Serum and Conditioned Medium
    Satou, Motoyasu
    Nishi, Yoshihiro
    Yoh, Junko
    Hattori, Yoshiyuki
    Sugimoto, Hiroyuki
    ENDOCRINOLOGY, 2010, 151 (10) : 4765 - 4775
  • [23] Author Correction: Identification of fungal lignocellulose-degrading biocatalysts secreted by Phanerochaete chrysosporium via activity-based protein profiling
    Christian Schmerling
    Leonard Sewald
    Geronimo Heilmann
    Frederick Witfeld
    Dominik Begerow
    Kenneth Jensen
    Christopher Bräsen
    Farnusch Kaschani
    Herman S. Overkleeft
    Bettina Siebers
    Markus Kaiser
    Communications Biology, 5
  • [24] Identification of a S. aureus virulence factor by activity-based protein profiling (ABPP)
    Lentz, Christian S.
    Sheldon, Jessica R.
    Crawford, Lisa A.
    Cooper, Rachel
    Garland, Megan
    Amieva, Manuel R.
    Weerapana, Eranthie
    Skaar, Eric P.
    Bogyo, Matthew
    NATURE CHEMICAL BIOLOGY, 2018, 14 (06) : 609 - +
  • [25] Activity-based protein profiling as a robust method for enzyme identification and screening in extremophilic Archaea
    Zweerink, Susanne
    Kallnik, Verena
    Ninck, Sabrina
    Nickel, Sabrina
    Verheyen, Julia
    Blum, Marcel
    Wagner, Alexander
    Feldmann, Ingo
    Sickmann, Albert
    Albers, Sonja-Verena
    Braesen, Christopher
    Kaschani, Farnusch
    Siebers, Bettina
    Kaiser, Markus
    NATURE COMMUNICATIONS, 2017, 8
  • [26] Identification of a S. aureus virulence factor by activity-based protein profiling (ABPP)
    Christian S. Lentz
    Jessica R. Sheldon
    Lisa A. Crawford
    Rachel Cooper
    Megan Garland
    Manuel R. Amieva
    Eranthie Weerapana
    Eric P. Skaar
    Matthew Bogyo
    Nature Chemical Biology, 2018, 14 : 609 - 617
  • [27] Site-Specific Activity-Based Protein Profiling Using Phosphonate Handles
    van Bergen, Wouter
    Hevler, Johannes F.
    Wu, Wei
    Baggelaar, Marc P.
    Heck, Albert J. R.
    MOLECULAR & CELLULAR PROTEOMICS, 2023, 22 (01)
  • [28] Activity-based protein profiling as a robust method for enzyme identification and screening in extremophilic Archaea
    Susanne Zweerink
    Verena Kallnik
    Sabrina Ninck
    Sabrina Nickel
    Julia Verheyen
    Marcel Blum
    Alexander Wagner
    Ingo Feldmann
    Albert Sickmann
    Sonja-Verena Albers
    Christopher Bräsen
    Farnusch Kaschani
    Bettina Siebers
    Markus Kaiser
    Nature Communications, 8
  • [29] Quantification of In Vivo Target Engagement Using Microfluidic Activity-Based Protein Profiling
    Reardon, Holly T.
    Herbst, Rachel A.
    Henry, Cassandra L.
    Herbst, Dylan M.
    Ngo, Nhi
    Cisar, Justin S.
    Weber, Olivia D.
    Niphakis, Micah J.
    O'Neill, Gary P.
    SLAS TECHNOLOGY, 2019, 24 (05): : 489 - 498
  • [30] Identification of cell wall synthesis inhibitors active against Mycobacterium tuberculosis by competitive activity-based protein profiling
    Li, Michael
    Patel, Hiren, V
    Cognetta, Armand B., III
    Smith, Trever C., II
    Mallick, Ivy
    Cavalier, Jean-Francois
    Previti, Mary L.
    Canaan, Stephane
    Aldridge, Bree B.
    Cravatt, Benjamin F.
    Seeliger, Jessica C.
    CELL CHEMICAL BIOLOGY, 2022, 29 (05) : 883 - +